ArticleOncology research2024

Tmem39b promotes tumor progression and sorafenib resistance by inhibiting ferroptosis in hepatocellular carcinoma.

Ming Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.